Clinical Trial Update: A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects [Phase 4]

View source ↗

Summary

A Phase 4 crossover trial evaluated the combination of ADOAIR twice daily plus tiotropium once daily against each monotherapy in Japanese patients with chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ADOAIR (fluticasone propionate/salmeterol)
• tiotropium bromide (tiotropium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2014-09-08